Table 2.
Demographic and clinical data of the comorbidity-controlled dataset.
Variables | LC* (N = 8) |
COPD (N = 7) |
ILD (N = 10) |
P value* |
---|---|---|---|---|
Age (yrs. ± SD) | 58.5 ± 14.1 | 56.7 ± 13.9 | 62.9 ± 12.3 | NS |
Sex, men N (%) | 5 (62.5) | 6 (85.7) | 8 (80.0) | NS |
Smoking status N (%) | ||||
Smoker | 3 (37.5) | 2 (28.6) | 2 (20.0) | NS |
Former smoker | 2 (25.0) | 3 (42.6) | 6 (60.0) | |
Non-smoker | 3 (37.5) | 2 (28.6) | 2 (20.0) | |
Pack Per Year | 37.6 ± 18.2 | 64.5 ± 37.4 | 35.7 ± 17.7 | NSa |
LC Diagnosis N (%) | ||||
NSCLC | 7 (87.5) | NA | ||
ADC | 5 (62.5) | |||
Unknown | 2 (25.0) | |||
SCLC | 1 (12.5) | |||
COPD Diagnosis N (%) | ||||
GOLD 2 | 5 (71.4) | NA | ||
Unknown | 2 (28.6) | |||
ILD Diagnosis N (%) | ||||
HP | 3 (30.0) | NA | ||
Sarcoidosis | 2 (20.0) | |||
IPF | 1 (10.0) | |||
Other | 4 (40.0) |
*P values based on Kruskal–Wallis test or chi-square (normal distributed or categorical variables, respectively) for the comparison of the three groups, lung cancer (LC), chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD). HP- Hypersensitivity pneumonitis; NS—Non-significant (p value > 0.05); NA—Not applicable. a—results based in pairwise Welch's t-tests.